A new type of protein–polymer conjugate provides improved stability without detrimentally affecting bioactivity, and thus offers great potential for the development of new peptide-based drugs.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile
Scientific Reports Open Access 19 March 2018
-
Chitosan Nanolayered Cisplatin-Loaded Lipid Nanoparticles for Enhanced Anticancer Efficacy in Cervical Cancer
Nanoscale Research Letters Open Access 25 November 2016
Access options
ENZYME: ©ISTOCKPHOTO.COM/MARTIN MCCARTHY
References
Leader, B., Baca, Q. J. & Golan, D. E. Nature Rev. Drug Discov. 7, 21–39 (2008).
Wild, S., Roglic, G., Green, A., Sicree, R. & King, H. Diabetes Care 27, 1047–1053 (2004).
Veronese, F. M. & Pasut, G. Drug Discov. Today 10, 1451–1458 (2005).
Veronese, F. M & Mero, A. Biodrugs 22, 315–329 (2008).
Bailon, P. et al. Bioconjugate Chem. 12, 195–202 (2001).
Keefe, A. J. & Jiang, S. Nature Chem. 4, 59–63 (2012).
Yang, W., Zhang, L., Wang, S., White, A. D. & Jiang, S. Biomaterials 30, 5617–5621 (2009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parrott, M., DeSimone, J. Relieving PEGylation. Nature Chem 4, 13–14 (2012). https://doi.org/10.1038/nchem.1230
Published:
Issue date:
DOI: https://doi.org/10.1038/nchem.1230
This article is cited by
-
Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile
Scientific Reports (2018)
-
Chitosan Nanolayered Cisplatin-Loaded Lipid Nanoparticles for Enhanced Anticancer Efficacy in Cervical Cancer
Nanoscale Research Letters (2016)
-
Orthogonal analysis of functional gold nanoparticles for biomedical applications
Analytical and Bioanalytical Chemistry (2015)
